MedPath

Use of Antibacterial Cement in Infected Dentin

Not Applicable
Completed
Conditions
Dental Caries
Interventions
Other: Antibacterial cement
Registration Number
NCT01449136
Lead Sponsor
University of Pernambuco
Brief Summary

Dental materials with antibacterial properties can prevent the harmful effects caused by oral cariogenic bacteria. This double-blind controlled clinical trial evaluated the performance of antibacterial cement for sealing infected dentin in atraumatic restorations of primary molars.

Detailed Description

The study enrolled 45 children (45 teeth) between 5 and 8 years of age, of both genders, divided into two groups. In group A (GA; n=22), the cavities were lined with conventional glass ionomer cement (Vidrion F®) and in group B (GB; n=23), with antibacterial cement (Vidrion F® containing 1% each of metronidazole, ciprofloxacin, and cefaclor). Both groups were restored with Ketac Molar Easymix®. Molars with carious lesions on the inner half of dentin without clinical or radiographic pulp damage were selected. Patients were evaluated clinically (for pain, fistulas, or mobility) and radiographically (area of caries, periapical region, and furcation of teeth) after 1, 3, 6, and 12 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • signed consent from a parent or guardian;
  • primary molars with carious lesions on the inner half of dentin;
  • access of caries lesions to dentin spoons.
Exclusion Criteria
  • damaged pulp determined clinically (for pain, fistulas, tooth mobility);
  • damaged pulp determined radiography (bone or dental pathology);
  • children taking antibiotics;
  • children who refused the treatment;
  • children had systemic disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
antibacterial cementAntibacterial cement-
Primary Outcome Measures
NameTimeMethod
number of successful restorations with a dental liner with antibioticsdifferences of overall success between baseline and the evaluations performed at 1, 3, 6, and 12 months.

The absence of pain, fistulas, and mobility throughout the study was considered clinical success and the decreased or unchanged area of caries (obtained by a software to accurately measure distances between anatomical points selected by the operator of radiolucent zone beneath the restoration) and no bone or dental disorder was detected was considered radiographic success.

Overall success was defined as clinical and radiographic success being achieved simultaneously.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UFPB

🇧🇷

João Pessoa, PB, Brazil

© Copyright 2025. All Rights Reserved by MedPath